This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through September 7, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical-devices: Archive
Here's Why You Should Hold Solventum Stock in Your Portfolio for Now
by Zacks Equity Research
SOLV's strong Q2 performance, growth investments and cost-saving program support its outlook, though higher raw material costs remain a concern.
SOLVPositive Net Change WSTNegative Net Change GMEDPositive Net Change VCYTPositive Net Change
medical medical-devices
BTSG Faces $200M IRA Hit but Efficiency May Protect Profitability
by Indrajit Bandyopadhyay
BTSG faces a $200M 2026 IRA revenue headwind in Home Pharmacy, but efficiency gains and technology are helping protect profitability.
BTSGPositive Net Change CAHNegative Net Change CVSPositive Net Change
medical medical-devices
BSX vs. MDT: Which Electrophysiology Stock Is the Better Bet Now?
by Moumi Mondal
Boston Scientific faces near-term pressure in electrophysiology, while Medtronic gains share and sees stronger momentum across key franchises.
BSXNegative Net Change MDTNegative Net Change
medical medical-devices
Top Stock Reports for Cisco, Lam Research & Thermo Fisher
by Mark Vickery
Cisco, Lam Research and Thermo Fisher headline today's research reports, with AI demand, customer activity and growth strategies in focus.
CSCOPositive Net Change TMOPositive Net Change LRCXPositive Net Change APPositive Net Change CLSTNegative Net Change AEEPositive Net Change NLYNegative Net Change DINOPositive Net Change
computers finance industrial-products medical-devices semiconductor
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
by Zacks Equity Research
CONMED's BioBrace and AirSeal platforms, robotic growth and easing supply bottlenecks support its long-term outlook despite tariff headwinds.
CNMDPositive Net Change GMEDPositive Net Change VCYTPositive Net Change INSPNegative Net Change
medical medical-devices
Can CAH Navigate IRA Pricing Changes Risk Without Margin Pressure?
by Indrajit Bandyopadhyay
Cardinal Health expects IRA pricing changes to pressure Pharma revenues while protecting profitability through compensation and durable distribution agreements.
CAHNegative Net Change CVSPositive Net Change BTSGPositive Net Change
medical medical-devices
GEHC Launches CareIntellect AI Tool to Optimize Hospital Operations
by Zacks Equity Research
GE HealthCare launches an AI-powered SaaS tool that predicts hospital capacity challenges up to 72 hours ahead and recommends actions to ease bottlenecks.
GEHCPositive Net Change GMEDPositive Net Change VCYTPositive Net Change INSPNegative Net Change
medical medical-devices
ISRG Wins EU Nod to Expand da Vinci SP in Gynecologic Procedures
by Zacks Equity Research
Intuitive Surgical's CE mark expands da Vinci SP into transvaginal gynecology in Europe, opening a new women's health opportunity and growth runway.
ISRGNegative Net Change WSTNegative Net Change GMEDPositive Net Change VCYTPositive Net Change
medical medical-devices
Here's Why You Should Add Avantor Stock to Your Portfolio for Now
by Zacks Equity Research
AVTR's strong Q2 results, improving orders and raised 2026 outlook support growth prospects, though BMP weakness and uneven demand remain concerns.
AVTRPositive Net Change WSTNegative Net Change GMEDPositive Net Change VCYTPositive Net Change
medical medical-devices
Should You Buy PMV Pharmaceuticals, Inc. (PMVP) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
PMVPPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines